Autoimmune Disease Diagnosis and Treatment

Laboratory Evaluation

• A systematic laboratory evaluation including complete blood count with differential, comprehensive metabolic panel, inflammatory markers, and disease-specific autoantibodies is essential for diagnosis, with treatment tailored to the specific condition identified, as recommended by the American College of Physicians and the American Academy of Allergy, Asthma, and Immunology 1, 2
• Urinalysis with protein/creatinine ratio, antinuclear antibodies (ANA), smooth muscle antibodies (SMA), anti-liver/kidney microsome type 1 (LKM-1), and antimitochondrial antibodies (AMA) are important tests for diagnosing autoimmune diseases, according to the American Association for Clinical Chemistry 1, 3
• Complement levels (C3, C4) and rheumatoid factor (RF) are also crucial in evaluating autoimmune diseases, as stated by the American College of Rheumatology 1, 2

Organ-Specific Testing

• Liver-specific tests, such as anti-F-actin, anti-SLA/LP, and anti-LC1, are necessary for diagnosing autoimmune liver diseases, as recommended by the American Association for the Study of Liver Diseases 3, 4
• Neurological tests, including CSF analysis, oligoclonal bands, anti-NMDA receptor antibodies, and MOG-IgG, are essential for diagnosing autoimmune neurological conditions, according to the American Academy of Neurology 5
• Pulmonary tests, such as GM-CSF antibody testing, are important for diagnosing autoimmune pulmonary alveolar proteinosis, as stated by the European Respiratory Society 6

Imaging Studies

• Dedicated organ-specific imaging, such as chest X-ray, ultrasound, MRI, and PET/CT scan, may be necessary for diagnosing and monitoring autoimmune diseases, as recommended by the American College of Radiology 1, 5

Treatment

• Corticosteroids, such as prednisone, are often the initial treatment for acute flares of autoimmune diseases, with a typical dose of 40-70 mg per day, as stated by the American College of Physicians 1
• Conventional immunosuppressants, such as methotrexate and azathioprine, may be used to treat autoimmune diseases, according to the American College of Rheumatology 1
• Rituximab may be used to treat refractory cases of certain autoimmune conditions, as recommended by the European Respiratory Society 6
• Plasmapheresis may be used to treat severe, treatment-resistant cases of autoimmune diseases, as stated by the European Respiratory Society 6
• Evaluate for specific organ involvement, including renal function with urinalysis, protein/creatinine ratio, and GFR, as recommended by the American Gastroenterological Association 7
• Risk-stratify patients based on comorbidities, and consider functional status, comorbidities, and frailty in treatment decisions, as suggested by the American Gastroenterological Association 8
• Use a multidisciplinary approach involving geriatricians, rheumatologists, and other specialists, and avoid systemic corticosteroids for maintenance therapy, as suggested by the American Gastroenterological Association 8
• Base candidacy for immunosuppressants on functional status and comorbidities, not just age, and consider agents with lower infection/malignancy risk when appropriate, as recommended by the American Gastroenterological Association 8
• Immunosuppressive treatment improves survival even in patients over 75 years, according to the Kidney International guidelines 9
• Monitor closely for adverse effects of corticosteroids, such as diabetes, hypertension, and osteoporosis, and balance oral administration convenience with efficacy and side effect profiles of immunosuppressants, as suggested by the American Gastroenterological Association 8
• Ensure appropriate vaccinations, including influenza, pneumococcal, and herpes zoster vaccines, before immunosuppression, as recommended by the American Gastroenterological Association 8
• Monitor for increased fracture risk and screen for skin and non-skin cancers, as suggested by the American Gastroenterological Association 8
• Monitor for renal involvement with urinalysis and creatinine, and consider kidney biopsy for persistent hematuria with proteinuria, as recommended by the Kidney International guidelines 9